オメガ3市場規模、シェア、動向、2031年までの世界予測

オメガ3市場は2026年に48億8,000万米ドルとなり、2031年には年平均成長率（CAGR）12.3%で87億3,000万米ドルに達するとMarketsandMarketsでは予測しています。オメガ3市場は、心血管の健康、認知機能、視覚、関節の健康、および乳児の脳の発達におけるEPAやDHAの役割に対する認識の高まりや、予防医療・機能性栄養への消費者の関心の高まりを背景に、急速に拡大しています。特に乳児用調製粉乳の分野では、認知・身体的発達における早期の栄養摂取（とりわけDHAやその他の必須栄養素の役割）の重要性に対する保護者の意識向上に加え、欧州、北米、中国などの地域において乳児用調製粉乳へのDHA添加が義務付けられたり推奨されたりしていることを受け、爆発的な成長を遂げています。しかし、研究開発に伴う高額なコストや魚油価格の不安定さは、今後のオメガ3市場の成長にとって課題となると予想されます。

調査範囲

本調査レポートでは、オメガ3市場を以下の区分で分析しています：種類（ドコサヘキサエン酸[DHA]、エイコサペンタエン酸[EPA]、α-リノレン酸[ALA]）、供給源（海洋由来[魚、藻類、オキアミ、その他]および植物由来[ナッツ・種子、植物油]）、用途（サプリメント、機能性食品・飲料、医薬品、乳児用調製粉乳、ペットフード・飼料）、形態（乾燥・粉末、液体）、製造技術（定性的分析：抽出、精製・浄化、濃縮・変換、カプセル化・安定化、発酵・バイオテクノロジー）、および地域（北米、欧州、アジア太平洋、南米、その他）。

本レポートは、オメガ3原料の市場成長に影響を与える主要因（促進要因、抑制要因、課題、機会など）に関する詳細情報を提供します。主要な業界プレーヤーについて徹底的な分析を行い、事業内容、サービス、主要戦略、契約・提携・合意、新製品の投入、M&A、およびオメガ3市場に関連する最近の動向についての知見を提供します。また、オメガ3市場のエコシステムにおける新興企業（スタートアップ）の競争分析も含まれています。さらに、技術分析、エコシステムおよび市場マッピング、特許・規制状況など、業界特有のトレンドについても網羅しています。

本レポートを購入する理由

本レポートは、市場のリーダー企業や新規参入企業に対し、オメガ3市場全体および各サブセグメントの収益に関する推定値を提供します。これにより、ステークホルダーは競争環境を把握し、自社の事業の立ち位置を明確にしたり、適切な市場参入戦略を策定したりするための知見を得ることができます。また、市場の動向を理解し、主要な市場促進要因、抑制要因、課題、機会に関する情報を入手するのにも役立ちます。

本レポートでは、以下の点に関する知見を提供します。

オメガ3市場の成長に影響を与える要因の分析：主要な促進要因（魚油の持続可能性への懸念に伴う、藻類由来オイルや植物性オメガ3［亜麻仁、チアシード、キャノーラ］の採用拡大）、阻害要因（1日の推奨摂取量や健康強調表示に関する消費者の認識不足）、機会（オメガ3の代替供給源開発に向けた研究の増加）、および課題（魚油価格の著しい変動）

• 製品開発・イノベーション：オメガ3市場における研究開発活動や新製品投入に関する詳細な知見
• 市場開拓：有望な市場に関する包括的な情報（地域ごとのオメガ3市場の分析）
• 市場の多角化：オメガ3市場における新たな供給源、未開拓地域、最近の動向、投資に関する網羅的な情報
• 競合分析：市場シェア、成長戦略、製品ラインナップ、ブランド・製品比較、製品展開状況などに関する
  競合分析：BASF SE（ドイツ）、Cargill, Incorporated（米国）、DSM-Firmenich（オランダ）、ADM（米国）、Kerry Group plc（アイルランド）、Aker BioMarine（ノルウェー）、Croda International PLC（英国）、Corbion（オランダ）、Pelagia AS（ノルウェー）、KD Pharma Group SA（スイス）など、オメガ3市場における主要企業の市場シェア、成長戦略、製品ラインナップ、ブランド・製品比較、および製品展開状況に関する詳細な分析。

Report Description

The omega-3 market is estimated to be USD 4.88 billion in 2026 and is projected to reach USD 8.73 billion by 2031, at a CAGR of 12.3%.

The omega-3 market is gaining significant traction, driven by the increasing recognition of the roles of EPA and DHA in cardiovascular health, cognitive function, vision, joint health, and infant brain development, as well as a growing consumer shift toward preventive healthcare and functional nutrition. The infant formula sector has witnessed explosive growth, driven by rising awareness among parents about the importance of early nutrition for cognitive and physical development, particularly the role of DHA and other essential nutrients, and regulatory mandates and recommendations in regions such as Europe, North America, and China requiring or encouraging DHA fortification in infant formula. However, high costs involved in R&D activities and unstable fish oil prices are expected to pose a challenge to the omega-3 market’s growth.

Disruptions in the omega-3 market may offer opportunities for players

The omega-3 market is undergoing fundamental shifts, opening up new opportunities for companies. One of the most significant changes is the shift toward sustainable and plant-based sources such as algal oil and fermentation-based omega-3, which eliminate fish oil supply concerns and resonate with vegan and green consumers. Regulatory updates, such as the mandatory fortification of DHA in infant nutrition and broader approvals for cardiovascular and cognitive well-being claims, are also driving steady demand in both developed and emerging markets. Meanwhile, technological advances such as microencapsulation are enhancing stability and flavor, allowing omega-3 to be incorporated in new food and beverage applications.

On the application front, Omega-3 is increasingly being used in pharmaceuticals, pet food, and aquaculture, apart from conventional supplements. Pharma-grade formulations for neurological and cardiovascular health are gaining momentum, while high-end pet food and fortified aquaculture feed are experiencing significant growth. Alongside growing demand for convenience formats of functional nutrition products (gummies, powders, RTDs) and increasing consumer spending on health supplement products in South America and the Asia Pacific, these trends are redefining the landscape of the market. Players who innovate in sourcing, product development, and sustainability have a good chance of securing growth in emerging markets.

The dietary supplement segment is projected to be one of the fastest-growing segments

The dietary supplement category is one of the major growth drivers for the omega-3 market as consumers place greater emphasis on preventive healthcare and turn to convenient solutions for heart, brain, eye, and joint well-being. Supported by regulatory approvals for health claims, supplements offer confidence and convenience, as advancements in delivery forms, such as softgels, gummies, and powders, make them attractive to people of all ages. This synergy of health consciousness, aging population, and product creativity is driving robust and consistent demand for omega-3 in dietary supplements.

The liquid form of omega-3 is expected to hold a larger share of the omega-3 market

The majority of commercial omega-3 comes from fish oil, algal oil, and krill oil, which are naturally liquid forms and commonly used in dietary supplements, infant formula, functional foods, and pharmaceuticals. Liquids can accommodate higher purity, greater bioavailability, and simpler inclusion in soft gels, emulsions, and fortified liquid food. While dry formulations (powders, microencapsulated omega-3) are increasing as a result of uses in gummies, powders, and bakery applications, the liquid form continues to hold a significant market share as it is the most cost-efficient, mass-produced, and immediately applicable state across industries.

The eicosapentaenoic acid (EPA) segment is expected to grow at a significant rate

The EPA has been shown to benefit heart health, including reducing triglyceride levels, decreasing inflammation, and improving overall cardiovascular function. As awareness of these health benefits increases among consumers, there is a growing demand for omega-3 supplements and fortified foods and beverages containing EPA, which contributes to the expansion of the omega-3 market.

The US is estimated to dominate the North American omega-3 market during the forecast period

The US is one of the largest global markets for omega-3. The consumption of omega-3-based products and supplements has increased significantly due to rising consumer awareness of their various health benefits and their availability in the US market. The omega-3 consumption pattern in the US is driven toward categories such as capsules, dietary supplements, and infant formula. However, the country has one of the largest consumer markets in the world. Recently, the EPA/DHA (omega-3) ingredients sector has experienced a surge in product innovations, introducing new omega-3 variants and expanding the utilization of plant-based sources. As consumers increasingly prioritize the health of oceans, there is a growing demand for plant-based omega-3 ingredients within the dietary supplement sector.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the omega-3 market.

• By Company Type: Tier 1 – 30%, Tier 2 – 25%, and Tier 3 – 45%
• By Designation: CXOs – 25%, Managers – 40%, Executives – 35%
• By Region: North America – 22%, Europe – 28%, Asia Pacific – 32%, South America – 10%, and Rest of the World – 8%

Prominent companies in the market include BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), and AlgaeCytes Limited (UK).

Research Coverage

This research report categorizes the omega-3 market by type (docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha-linolenic acid (ALA)), source (marine [fish, algal, krill, and other marine sources] and plant [nuts & seeds and vegetable oils]), application (dietary supplements, functional foods & beverages, pharmaceuticals, infant formulas, and pet food and feed), form (dry and liquid), manufacturing technology (qualitative) (extraction, refining & purification, concentration & conversion, encapsulation & stabilization, and fermentation & biotechnology), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of omega-3 ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the omega-3 market. This report covers the competitive analysis of upcoming startups in the omega-3 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscapes, among others.

Reasons to Buy This Report

The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall omega-3 and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (Rising adoption of algal oil and plant-based omega-3 (flaxseed, chia, canola) due to concerns over fish oil sustainability), restraints (lack of clarity among consumers about daily recommended intake and health claims), opportunities (increase in research for development of alternative sources to obtain omega-3), and challenges (highly unstable fish oil prices) influencing the growth of the omega-3 market
• Product Development/Innovation: Detailed insights on research & development activities and new product launches in the omega-3 market
• Market Development: Comprehensive information about lucrative markets—the report analyzes omega-3 across varied regions
• Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the omega-3 market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), and other players in the omega-3 market

Table of Contents

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE 30
1.3.1 MARKETS COVERED AND REGIONS CONSIDERED 30
1.3.2 INCLUSIONS AND EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 32
1.3.4 CURRENCY CONSIDERED 32
1.3.5 UNITS CONSIDERED 33
1.4 STAKEHOLDERS 33
1.5 SUMMARY OF CHANGES 34
2 EXECUTIVE SUMMARY 35
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 35
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 37
2.3 DISRUPTIVE TRENDS IN OMEGA-3 MARKET 38
2.4 HIGH-GROWTH SEGMENTS 39
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 40
3 PREMIUM INSIGHTS 41
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET 41
3.2 OMEGA-3 MARKET, BY TYPE AND REGION 42
3.3 OMEGA-3 MARKET, BY 3 TYPES 42
3.4 OMEGA-3 MARKET, BY SOURCE 43
3.5 OMEGA-3 MARKET, BY FORM 43
3.6 OMEGA-3 MARKET, BY APPLICATION 43
3.7 OMEGA-3 MARKET, BY COUNTRY 44
4 MARKET OVERVIEW 45
4.1 INTRODUCTION 45
4.2 MARKET DYNAMICS 46
4.2.1 DRIVERS 46
4.2.1.1 Growing consumer awareness regarding health benefits 46
4.2.1.2 Increasing use in food and feed products 48
4.2.1.2.1 Rising demand for mother and infant nutrition products 48
4.2.1.2.2 Mandatory inclusion of algal DHA in infant formula 48
4.2.1.2.3 Growth focus of food processing companies on fortification 48
4.2.1.2.4 Increasing applications in pet food and feed 49
4.2.1.3 Shift toward pharmaceutical-grade high-concentrate omega-3 oils in developed markets 50
4.2.1.4 Emergence of innovative production technologies 50
4.2.2 RESTRAINTS 52
4.2.2.1 Declining fish oil supply due to sustainability issues in fisheries 52
4.2.2.2 Lack of clarity on daily intake recommendations and health claims 53
4.2.3 OPPORTUNITIES 53
4.2.3.1 Increasing research on alternative sources 53
4.2.3.1.1 Rising consumer demand for plant-based products 54
4.2.3.1.2 Growing focus on microalgae-based omega-3 production 55
4.2.3.1.3 Side effects and allergies related to fish-based products 55
4.2.3.2 Favorable regulatory environment 56
4.2.3.3 Integration of microencapsulation technology 56
4.2.4 CHALLENGES 57
4.2.4.1 High costs involved in R&D activities 57
4.2.4.2 Volatility in fish oil prices 57
4.2.4.3 Instability of omega-3 oils 58
4.3 UNMET NEEDS AND WHITE SPACES 58
4.3.1 UNMET NEEDS IN THE OMEGA 3 MARKET 58
4.3.2 WHITE SPACE OPPORTUNITIES 59
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 60
4.4.1 INTERCONNECTED MARKETS 60
4.4.2 CROSS SECTOR OPPORTUNITIES 61
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 62
5 INDUSTRY TRENDS 63
5.1 PORTER’S FIVE FORCES ANALYSIS 63
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 64
5.1.2 BARGAINING POWER OF SUPPLIERS 64
5.1.3 BARGAINING POWER OF BUYERS 64
5.1.4 THREAT OF SUBSTITUTES 65
5.1.5 THREAT OF NEW ENTRANTS 65
5.2 MACROECONOMIC OUTLOOK 65
5.2.1 INTRODUCTION 65
5.3 MACROECONOMIC INDICATORS 65
5.3.1 SUSTAINABILITY AND CIRCULAR ECONOMY INITIATIVES 65
5.3.2 PREVENTIVE HEALTHCARE EXPENDITURE 66
5.3.3 GROWING GERIATRIC POPULATION 67

5.4 VALUE CHAIN ANALYSIS 68
5.4.1 RESEARCH AND PRODUCT DEVELOPMENT 68
5.4.2 SOURCING 69
5.4.3 PRODUCTION AND PROCESSING 69
5.4.4 DISTRIBUTION 69
5.4.5 MARKETING AND SALES 69
5.4.6 END USERS 69
5.5 ECOSYSTEM ANALYSIS 70
5.5.1 DEMAND SIDE 70
5.5.2 SUPPLY SIDE 70
5.6 PRICING ANALYSIS 72
5.6.1 INTRODUCTION 72
5.6.2 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE 72
5.6.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION 73
5.6.4 AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE 74
5.7 TRADE ANALYSIS 75
5.7.1 IMPORT ANALYSIS: OMEGA-3 75
5.7.2 EXPORT ANALYSIS: OMEGA-3 76
5.8 KEY CONFERENCES AND EVENTS, 2026–2027 77
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78
5.10 INVESTMENT AND FUNDING SCENARIO 78
5.11 CASE STUDY ANALYSIS 79
5.11.1 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY 79
5.11.2 KD PHARMA GROUP: ADVANCING PHARMACEUTICAL-GRADE OMEGA-3 PURIFICATION TECHNOLOGIES 79
5.11.3 VERAMARIS: PIONEERING SUSTAINABLE OMEGA-3 SOLUTIONS IN AQUACULTURE 80
5.11.4 DSM-FIRMENICH: EXPANDING ALGAE-DERIVED DHA ACROSS LIFE-STAGE NUTRITION 80
5.11.5 AKER BIOMARINE EXPANDED EUROPEAN MARKET ACCESS THROUGH STRATEGIC DISTRIBUTION PARTNERSHIPS 81
5.12 IMPACT OF 2025 US TARIFFS – OMEGA-3 MARKET 81
5.12.1 INTRODUCTION 81
5.12.2 PRICE IMPACT ANALYSIS 82
5.12.3 IMPACT ON COUNTRIES/REGIONS 82
5.12.3.1 US 82
5.12.3.2 Europe 82
5.12.3.3 Asia Pacific 82
5.12.4 IMPACT ON END-USE INDUSTRIES 83

6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 84
6.1 TECHNOLOGY ANALYSIS 84
6.1.1 KEY TECHNOLOGIES 84
6.1.1.1 Molecular distillation 84
6.1.1.2 Supercritical CO₂ extraction 85
6.1.1.3 Algae fermentation 85
6.1.2 COMPLEMENTARY TECHNOLOGIES 86
6.1.2.1 Stabilization & antioxidant technologies 86
6.1.2.2 Microencapsulation 86
6.1.3 ADJACENT TECHNOLOGIES 86
6.1.3.1 Precision fermentation 86
6.1.3.2 Synthetic biology & bioprocess engineering 87
6.1.4 TECHNOLOGY/PRODUCT ROADMAP 87
6.1.4.1 Short-Term | High-Purity Omega-3 Production & Stability Enhancement 87
6.1.4.2 Mid-Term | Sustainable EPA & DHA Manufacturing 87
6.1.4.3 Long-Term | Precision Nutrition & Next-Generation Omega-3 Innovation 87
6.2 PATENT ANALYSIS 88
6.3 FUTURE APPLICATIONS 89
6.3.1 CLINICAL NUTRITION & HEALTHY AGING: EXPANDING THE FUTURE OF OMEGA-3 APPLICATIONS 90
6.3.2 STABLE DHA-ENRICHED FUNCTIONAL FOODS: ADVANCING THE NEXT GENERATION OF OMEGA-3 NUTRITION 90
6.3.3 PLANT-BASED OMEGA-3 SUPPLEMENTATION: ENABLING THE FUTURE OF PERSONALIZED VEGAN NUTRITION 91
6.3.4 OMEGA-3 BIOMARKER-BASED PRENATAL NUTRITION: ENABLING PRECISION MATERNAL HEALTHCARE 91
6.4 IMPACT OF GENERATIVE AI ON OMEGA 3 MARKET 92
6.4.1 INTRODUCTION 92
6.4.2 TOP USE CASES AND MARKET POTENTIAL 92
6.4.3 BEST PRACTICES IN OMEGA 3 INDUSTRY 93
6.4.4 CASE STUDIES OF AI IMPLEMENTATION IN OMEGA 3 MARKET 93
6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 94
6.4.6 CLIENTS’ READINESS TO ADOPT GENERATIVE AI FOR OMEGA 3 PRODUCTION 94
6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 95

7 SUSTAINABILITY AND REGULATORY LANDSCAPE 96
7.1 REGIONAL REGULATIONS AND COMPLIANCE 96
7.1.1 INDUSTRY STANDARDS 99
7.1.2 LABELING REQUIREMENTS AND CLAIMS 100
7.1.3 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS 101
7.1.3.1 Enhanced Traceability and Sustainability Requirements 101
7.1.3.2 Global Harmonization of Omega-3 Labeling and Health Claims 101
7.1.3.3 Stricter Quality, Purity, and Contaminant Standards 101
7.1.3.4 Digital Traceability, AI-Enabled Quality Monitoring, and Compliance Automation 101
7.1.3.5 Stronger Sustainability and ESG Compliance Requirements 101
7.2 SUSTAINABILITY INITIATIVES 101
7.2.1 SUSTAINABLE SOURCING 102
7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 102
7.2.3 CIRCULAR ECONOMY APPROACHES 103
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 103
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 103
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 105
8.1 DECISION-MAKING PROCESS 105
8.2 KEY STAKEHOLDERS AND BUYING CRITERIA 107
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 107
8.2.2 BUYING CRITERIA 108
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 109
8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 110
8.5 MARKET PROFITABILITY 111
8.6 REVENUE POTENTIAL 112
8.6.1 COST DYNAMICS 112
9 OMEGA-3 MARKET, BY TYPE 114
9.1 INTRODUCTION 115
9.2 DOCOSAHEXAENOIC ACID 116
9.2.1 NEED FOR PROTECTION AGAINST ALZHEIMER’S DISEASE TO DRIVE DEMAND 116
9.3 EICOSAPENTAENOIC ACID 118
9.3.1 ABILITY TO REDUCE SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND 118
9.4 ALPHA-LINOLENIC ACID 119
9.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND 119

10 OMEGA-3 MARKET, BY SOURCE 121
10.1 INTRODUCTION 122
10.2 MARINE 123
10.2.1 NEED FOR HEALTHY FETAL DEVELOPMENT IN PREGNANT WOMEN TO DRIVE MARKET 123
10.2.2 FISH 126
10.2.2.1 Anchovy 127
10.2.2.2 Sardine 127
10.2.2.3 Mackerel 127
10.2.2.4 Other fish types 127
10.2.3 ALGAE 128
10.2.3.1 Schizochytrium sp. 128
10.2.3.2 Crypthecodinium cohnii 129
10.2.3.3 Nannochloropsis sp. 129
10.2.3.4 Other algae types 129
10.2.4 KRILL 129
10.2.5 OTHER MARINE SOURCES 130
10.3 PLANT 131
10.3.1 GROWING USE OF FLAX SEEDS FOR CANCER PREVENTION TO BOOST DEMAND 131
10.3.2 NUTS & SEEDS 133
10.3.3 VEGETABLE OILS 134
11 OMEGA-3 MARKET, BY APPLICATION 136
11.1 INTRODUCTION 137
11.2 DIETARY SUPPLEMENTS 138
11.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIETS TO DRIVE DEMAND 138
11.3 FUNCTIONAL FOODS & BEVERAGES 139
11.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND 139
11.3.2 DAIRY & DAIRY ALTERNATIVES 140
11.3.3 BAKERY & CEREAL PRODUCTS 141
11.3.4 CONFECTIONERY PRODUCTS 141
11.3.5 MEAT & MEAT PRODUCTS 141
11.3.6 BEVERAGES 141
11.3.7 OTHER FUNCTIONAL FOOD PRODUCTS 142
11.4 PHARMACEUTICALS 142
11.4.1 GROWING NEED TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET 142
11.5 INFANT FORMULAS 143
11.5.1 RISING CONSUMPTION OF OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND 143

11.6 PET FOOD & FEED 144
11.6.1 GREATER EMPHASIS ON ENHANCING IMMUNITY IN PETS TO DRIVE MARKET 144
11.6.2 PET FOOD 145
11.6.3 ANIMAL FEED 145
12 OMEGA-3 MARKET, BY FORM 146
12.1 INTRODUCTION 147
12.2 DRY 148
12.2.1 ENCAPSULATED STABILITY MEETS VERSATILE APPLICATIONS 148
12.3 LIQUID 149
12.3.1 HIGH BIOAVAILABILITY AND EFFICACY TO FUEL DEMAND 149
13 OMEGA 3 MARKET, BY MANUFACTURING TECHNOLOGY 151
13.1 INTRODUCTION 151
13.2 EXTRACTION 151
13.3 REFINING & PURIFICATION 151
13.4 CONCENTRATION & CONVERSION 152
13.5 ENCAPSULATION & STABILIZATION 152
13.6 FERMENTATION & BIOTECHNOLOGY 152
14 OMEGA-3 MARKET, BY REGION 154
14.1 INTRODUCTION 155
14.2 NORTH AMERICA 158
14.2.1 US 163
14.2.1.1 Growing incorporation of omega-3 in dietary supplements to drive market 163
14.2.2 CANADA 164
14.2.2.1 Increasing application in functional foods & beverages to boost market 164
14.2.3 MEXICO 166
14.2.3.1 Growing focus on heart disease prevention to drive market 166
14.3 EUROPE 168
14.3.1 GERMANY 172
14.3.1.1 Low fish consumption to boost demand for omega-3-based supplements 172
14.3.2 UK 173
14.3.2.1 Rising gastrointestinal health awareness supporting Omega-3 demand 173
14.3.3 FRANCE 175
14.3.3.1 Rising cardiovascular disease burden driving Omega-3 consumption 175
14.3.4 NORWAY 177
14.3.4.1 Production of genetically modified canola to offer lucrative growth opportunities to market players 177

14.3.5 ITALY 178
14.3.5.1 High production of dietary supplements, functional food products, and beverages to boost market 178
14.3.6 SPAIN 179
14.3.6.1 Rising consumer awareness and dietary gaps to drive market 179
14.3.7 NETHERLANDS 181
14.3.7.1 Growing incidences of depression, autism, and ADHD to drive market 181
14.3.8 REST OF EUROPE 182
14.4 ASIA PACIFIC 184
14.4.1 CHINA 189
14.4.1.1 Increasing focus on product innovations and diversification to drive market 189
14.4.2 INDIA 191
14.4.2.1 Growing incidences of heart failure to drive market 191
14.4.3 JAPAN 192
14.4.3.1 Rapidly aging population driving demand for Omega-3 supplements 192
14.4.4 AUSTRALIA & NEW ZEALAND 194
14.4.4.1 Government-led initiatives to increase awareness regarding omega-3 to drive market 194
14.4.5 REST OF ASIA PACIFIC 196
14.5 SOUTH AMERICA 197
14.5.1 BRAZIL 201
14.5.1.1 Rising demand for algal oils to drive market 201
14.5.2 ARGENTINA 203
14.5.2.1 Commercialization of omega-3 products to fuel market 203
14.5.3 REST OF SOUTH AMERICA 204
14.6 REST OF THE WORLD (ROW) 205
14.6.1 AFRICA 209
14.6.1.1 Prevalence of undernutrition among pregnant women and children to drive market 209
14.6.2 MIDDLE EAST 210
14.6.2.1 Ongoing innovations in omega-3 products to drive market 210
15 COMPETITIVE LANDSCAPE 212
15.1 OVERVIEW 212
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 212
15.3 REVENUE ANALYSIS 214
15.4 MARKET SHARE ANALYSIS 215
15.5 COMPANY VALUATION AND FINANCIAL METRICS 218
15.6 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON 219
15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 220
15.7.1 STARS 221
15.7.2 EMERGING LEADERS 221
15.7.3 PERVASIVE PLAYERS 221
15.7.4 PARTICIPANTS 221
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS 223
15.7.5.1 Company footprint 223
15.7.5.2 Regional footprint 223
15.7.5.3 Source footprint 224
15.7.5.4 Type footprint 225
15.7.5.5 Application footprint 225
15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 226
15.8.1 PROGRESSIVE COMPANIES 226
15.8.2 RESPONSIVE COMPANIES 226
15.8.3 DYNAMIC COMPANIES 226
15.8.4 STARTING BLOCKS 227
15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 228
15.9 COMPETITIVE SCENARIO AND TRENDS 230
15.9.1 OMEGA-3 MARKET: PRODUCT LAUNCHES 230
15.9.2 DEALS 231
15.9.3 EXPANSIONS 233
16 COMPANY PROFILES 234
16.1 KEY PLAYERS 234
16.1.1 DSM-FIRMENICH 234
16.1.1.1 Business overview 234
16.1.1.2 Products/Solutions/Services offered 235
16.1.1.3 Recent developments 236
16.1.1.3.1 Product launches and enhancements 236
16.1.1.4 MnM view 236
16.1.1.4.1 Key strengths 236
16.1.1.4.2 Strategic choices 236
16.1.1.4.3 Weaknesses and competitive threats 237
16.1.2 CARGILL, INCORPORATED 238
16.1.2.1 Business overview 238
16.1.2.2 Products/Solutions/Services offered 239
16.1.2.3 Recent developments 240
16.1.2.3.1 Deals 240
16.1.2.4 MnM view 240
16.1.2.4.1 Key strengths 240
16.1.2.4.2 Strategic choices 240
16.1.2.4.3 Weaknesses and competitive threats 240

16.1.3 BASF SE 241
16.1.3.1 Business overview 241
16.1.3.2 Products/Solutions/Services offered 242
16.1.3.3 Recent developments 243
16.1.3.3.1 Deals 243
16.1.3.4 MnM view 243
16.1.3.4.1 Key strengths 243
16.1.3.4.2 Strategic choices 243
16.1.3.4.3 Weaknesses and competitive threats 243
16.1.4 ADM 244
16.1.4.1 Business overview 244
16.1.4.2 Products/Solutions/Services offered 245
16.1.4.3 MnM view 246
16.1.4.3.1 Key strengths 246
16.1.4.3.2 Strategic choices 246
16.1.4.3.3 Weaknesses and competitive threats 246
16.1.5 KERRY GROUP PLC 247
16.1.5.1 Business overview 247
16.1.5.2 Products/Solutions/Services offered 248
16.1.5.3 Recent developments 249
16.1.5.3.1 Deals 249
16.1.5.4 MnM view 249
16.1.5.4.1 Key strengths 249
16.1.5.4.2 Strategic choices 249
16.1.5.4.3 Weaknesses and competitive threats 250
16.1.6 CORBION 251
16.1.6.1 Business overview 251
16.1.6.2 Products/Solutions/Services offered 252
16.1.6.3 Recent developments 253
16.1.6.3.1 Product launches and enhancements 253
16.1.6.3.2 Other developments 253
16.1.6.4 MnM view 253
16.1.7 KD PHARMA GROUP SA 254
16.1.7.1 Business overview 254
16.1.7.2 Products/Solutions/Services offered 255
16.1.7.3 Recent developments 257
16.1.7.3.1 Deals 257
16.1.7.3.2 Expansions 257
16.1.7.4 MnM view 258

16.1.8 AKER BIOMARINE 259
16.1.8.1 Business overview 259
16.1.8.2 Products/Solutions/Services offered 260
16.1.8.3 Recent developments 261
16.1.8.3.1 Product launches and enhancements 261
16.1.8.3.2 Expansions 262
16.1.8.3.3 Deals 262
16.1.8.3.4 Other developments 265
16.1.8.4 MnM view 265
16.1.9 CRODA INTERNATIONAL PLC 266
16.1.9.1 Business overview 266
16.1.9.2 Products/Solutions/Services offered 267
16.1.9.3 MnM view 268
16.1.10 EVONIK INDUSTRIES AG 269
16.1.10.1 Business overview 269
16.1.10.2 Products/Solutions/Services offered 270
16.1.10.3 Recent developments 271
16.1.10.3.1 Deals 271
16.1.10.4 MnM view 272
16.1.11 PELAGIA 273
16.1.11.1 Business overview 273
16.1.11.2 Products/Solutions/Services offered 274
16.1.11.3 Recent developments 275
16.1.11.3.1 Product launches and enhancements 275
16.1.11.3.2 Other developments 275
16.1.11.4 MnM view 276
16.1.12 GC RIEBER 277
16.1.12.1 Business overview 277
16.1.12.2 Products/Solutions/Services offered 278
16.1.12.3 Recent developments 279
16.1.12.3.1 Product launches and enhancements 279
16.1.12.3.2 Expansions 279
16.1.12.4 MnM view 280
16.1.13 COOKE AQUACULTURE INC. 281
16.1.13.1 Business overview 281
16.1.13.2 Products/Solutions/Services offered 281
16.1.13.3 Recent developments 283
16.1.13.3.1 Deals 283
16.1.13.4 MnM view 283

16.1.14 ALGISYS BIOSCIENCES, INC. 284
16.1.14.1 Business overview 284
16.1.14.2 Products/Solutions/Services offered 284
16.1.14.3 Recent developments 285
16.1.14.3.1 Other developments 285
16.1.14.4 MnM view 285
16.1.15 POLARIS 286
16.1.15.1 Business overview 286
16.1.15.2 Products/Solutions/Services offered 286
16.1.15.3 Recent developments 287
16.1.15.3.1 Product launches and enhancements 287
16.1.15.3.2 Other developments 287
16.1.15.4 MnM view 287
16.2 OTHER PLAYERS 288
16.2.1 BTSA 288
16.2.1.1 Business overview 288
16.2.1.2 Products/Solutions/Services offered 288
16.2.1.3 MnM view 289
16.2.2 NOVOSANA EUROPE B.V. 290
16.2.2.1 Business overview 290
16.2.2.2 Products/Solutions/Services offered 290
16.2.2.3 MnM view 291
16.2.3 GOLDEN OMEGA 292
16.2.3.1 Business overview 292
16.2.3.2 Products/Solutions/Services offered 292
16.2.3.3 Recent developments 293
16.2.3.3.1 Deals 293
16.2.3.4 MnM view 293
16.2.4 KINOMEGA BIOPHARM INC. 294
16.2.4.1 Business overview 294
16.2.4.2 Products/Solutions/Services offered 294
16.2.4.3 MnM view 295
16.2.5 RIMFROST AS 296
16.2.5.1 Business overview 296
16.2.5.2 Products/Solutions/Services offered 296
16.2.5.3 Recent developments 297
16.2.5.3.1 Deals 297
16.2.5.4 MnM view 297
16.2.6 ALGARITHM 298
16.2.7 SOLUTEX 298
16.2.8 CELLANA INC. 299
16.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD. 299
16.2.10 ALGAECYTES LIMITED 300
17 RESEARCH METHODOLOGY 301
17.1 RESEARCH DATA 301
17.1.1 SECONDARY DATA 301
17.1.1.1 Key data from secondary sources 302
17.1.2 PRIMARY DATA 302
17.1.2.1 Key data from primary sources 303
17.1.2.2 Breakdown of primary profiles 303
17.1.2.3 Key insights from industry experts 304
17.2 MARKET SIZE ESTIMATION 304
17.2.1 TOP-DOWN APPROACH 305
17.2.2 SUPPLY-SIDE ANALYSIS 306
17.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 306
17.3 DATA TRIANGULATION AND MARKET BREAKUP 308
17.4 RESEARCH ASSUMPTIONS 309
17.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 310
18 ADJACENT & RELATED MARKETS 311
18.1 INTRODUCTION 311
18.2 STUDY LIMITATIONS 311
18.3 FUNCTIONAL FOOD INGREDIENTS MARKET 311
18.3.1 MARKET DEFINITION 311
18.3.2 MARKET OVERVIEW 312
18.4 MARINE COLLAGEN MARKET 313
18.4.1 MARKET DEFINITION 313
18.4.2 MARKET OVERVIEW 313
19 APPENDIX 315
19.1 DISCUSSION GUIDE 315
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 322
19.3 CUSTOMIZATION OPTIONS 324
19.4 RELATED REPORTS 324
19.5 AUTHOR DETAILS 325

LIST OF TABLES

TABLE 1 INCLUSIONS AND EXCLUSIONS 31
TABLE 2 USD EXCHANGE RATES, 2021–2025 33
TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION 47
TABLE 4 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS 54
TABLE 5 KEY MOVES AND STRATEGIC FOCUS 62
TABLE 6 OMEGA-3 MARKET: PORTER’S FIVE FORCES ANALYSIS 64
TABLE 7 OMEGA-3 MARKET: SUPPLY CHAIN (ECOSYSTEM) 71
TABLE 8 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON) 73
TABLE 9 AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE, 2022–2025 (USD/TON) 74
TABLE 10 TOP IMPORTERS OF OMEGA-3, 2022–2025 (USD) 76
TABLE 11 TOP EXPORTERS OF OMEGA-3, 2022–2025 (USD) 77
TABLE 12 OMEGA-3 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 77
TABLE 13 PATENTS PERTAINING TO OMEGA 3 MARKET, 2021–2026 88
TABLE 14 TOP USE CASES AND MARKET POTENTIAL 92
TABLE 15 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 93
TABLE 16 OMEGA 3 MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 93
TABLE 17 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 94
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 21 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 23 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 24 INDUSTRY STANDARDS IN OMEGA-3 MARKET 99
TABLE 25 LABELING REQUIREMENTS AND CLAIMS IN OMEGA-3 MARKET 100
TABLE 26 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN OMEGA-3 MARKET 104
TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES 108
TABLE 28 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 108
TABLE 29 UNMET NEEDS IN OMEGA MARKET, BY APPLICATION INDUSTRIES ACROSS THE SUPPLY CHAIN 110
TABLE 30 COST DYNAMICS IN OMEGA 3 MARKET 112
TABLE 31 OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 116
TABLE 32 OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 116
TABLE 33 FOOD SOURCES FOR DHA (GRAMS PER SERVING) 117
TABLE 34 DOCOSAHEXAENOIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION) 117
TABLE 35 DOCOSAHEXAENOIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION) 118
TABLE 36 FOOD SOURCES FOR EPA (GRAMS PER SERVING) 118
TABLE 37 EICOSAPENTAENOIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION) 119
TABLE 38 EICOSAPENTAENOIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION) 119
TABLE 39 FOOD SOURCES FOR ALA (GRAMS PER SERVING) 120
TABLE 40 ALPHA-LINOLENIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION) 120
TABLE 41 ALPHA-LINOLENIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION) 120
TABLE 42 OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 122
TABLE 43 OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 122
TABLE 44 OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 123
TABLE 45 OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 123
TABLE 46 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS 124
TABLE 47 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION,
2022–2025 (USD MILLION) 124
TABLE 48 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION,
2026–2031 (USD MILLION) 125
TABLE 49 OMEGA-3 MARKET FROM MARINE SOURCE, BY REGION, 2022–2025 (KILOTONS) 125
TABLE 50 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2026–2031 (KILOTONS) 125
TABLE 51 OMEGA-3 MARKET FROM MARINE SOURCES, BY SOURCE TYPE,
2022–2025 (USD MILLION) 126
TABLE 52 OMEGA-3 MARKET FROM MARINE SOURCES, BY SOURCE TYPE,
2026–2031 (USD MILLION) 126
TABLE 53 OMEGA-3 MARKET FROM FISH, BY REGION, 2022–2025 (USD MILLION) 126
TABLE 54 OMEGA-3 MARKET FROM FISH, BY REGION, 2026–2031 (USD MILLION) 127
TABLE 55 OMEGA-3 MARKET FROM ALGAE, BY REGION, 2022–2025 (USD MILLION) 128
TABLE 56 OMEGA-3 MARKET FROM ALGAE, BY REGION, 2026–2031 (USD MILLION) 128
TABLE 57 OMEGA-3 MARKET FROM KRILL, BY REGION, 2022–2025 (USD MILLION) 130
TABLE 58 OMEGA-3 MARKET FROM KRILL, BY REGION, 2026–2031 (USD MILLION) 130
TABLE 59 OMEGA-3 MARKET FROM OTHER MARINE SOURCES, BY REGION,
2022–2025 (USD MILLION) 131
TABLE 60 OMEGA-3 MARKET FROM OTHER MARINE SOURCES, BY REGION,
2026–2031 (USD MILLION) 131
TABLE 61 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION,
2022–2025 (USD MILLION) 132
TABLE 62 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION,
2026–2031 (USD MILLION) 132
TABLE 63 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2022–2025 (KILOTONS) 132
TABLE 64 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2026–2031 (KILOTONS) 133
TABLE 65 OMEGA-3 MARKET FROM PLANT SOURCES, BY SOURCE TYPE,
2022–2025 (USD MILLION) 133
TABLE 66 OMEGA-3 MARKET FROM PLANT SOURCES, BY SOURCE TYPE,
2026–2031 (USD MILLION) 133
TABLE 67 OMEGA-3 MARKET FROM NUTS & SEEDS, BY REGION, 2022–2025 (USD MILLION) 134
TABLE 68 OMEGA-3 MARKET FROM NUTS & SEEDS, BY REGION, 2026–2031 (USD MILLION) 134
TABLE 69 OMEGA-3 MARKET FROM VEGETABLE OILS, BY REGION, 2022–2025 (USD MILLION) 135
TABLE 70 OMEGA-3 MARKET FROM VEGETABLE OILS, BY REGION, 2026–2031 (USD MILLION) 135
TABLE 71 OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 137
TABLE 72 OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 138
TABLE 73 OMEGA-3 MARKET IN DIETARY SUPPLEMENTS, BY REGION,
2022–2025 (USD MILLION) 139
TABLE 74 OMEGA-3 MARKET IN DIETARY SUPPLEMENTS, BY REGION,
2026–2031 (USD MILLION) 139
TABLE 75 OMEGA-3 MARKET IN FUNCTIONAL FOODS & BEVERAGES, BY REGION,
2022–2025 (USD MILLION) 140
TABLE 76 OMEGA-3 MARKET IN FUNCTIONAL FOODS & BEVERAGES, BY REGION,
2026–2031 (USD MILLION) 140
TABLE 77 OMEGA-3 MARKET IN PHARMACEUTICALS, BY REGION,
2022–2025 (USD MILLION) 142
TABLE 78 OMEGA-3 MARKET IN PHARMACEUTICALS, BY REGION,
2026–2031 (USD MILLION) 143
TABLE 79 OMEGA-3 MARKET IN INFANT FORMULAS, BY REGION, 2022–2025 (USD MILLION) 143
TABLE 80 OMEGA-3 MARKET IN INFANT FORMULAS, BY REGION, 2026–2031 (USD MILLION) 144
TABLE 81 OMEGA-3 MARKET IN PET FOOD & FEED, BY REGION, 2022–2025 (USD MILLION) 144
TABLE 82 OMEGA-3 MARKET IN PET FOOD & FEED, BY REGION, 2026–2031 (USD MILLION) 145
TABLE 83 OMEGA-3 MARKET, BY FORM, 2022–2025 (USD MILLION) 147
TABLE 84 OMEGA-3 MARKET, BY FORM, 2026–2031 (USD MILLION) 147
TABLE 85 DRY OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 148
TABLE 86 DRY OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 148
TABLE 87 LIQUID OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 149
TABLE 88 LIQUID OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 150
TABLE 89 OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 156
TABLE 90 OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 157
TABLE 91 OMEGA-3 MARKET, BY REGION, 2022–2025 (KILOTONS) 157
TABLE 92 OMEGA-3 MARKET, BY REGION, 2026–2031 (KILOTONS) 157
TABLE 93 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 159
TABLE 94 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 159
TABLE 95 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 160
TABLE 96 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 160
TABLE 97 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 160
TABLE 98 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 160
TABLE 99 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 161
TABLE 100 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 161
TABLE 101 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 161
TABLE 102 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 161
TABLE 103 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2022–2025 (USD MILLION) 162
TABLE 104 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2026–2031 (USD MILLION) 162
TABLE 105 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2022–2025 (USD MILLION) 162
TABLE 106 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2026–2031 (USD MILLION) 162
TABLE 107 US: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 163
TABLE 108 US: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 163
TABLE 109 US: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 164
TABLE 110 US: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 164
TABLE 111 CANADA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 165
TABLE 112 CANADA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 165
TABLE 113 CANADA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 165
TABLE 114 CANADA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 165
TABLE 115 MEXICO: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 166
TABLE 116 MEXICO: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 167
TABLE 117 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 167
TABLE 118 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 167
TABLE 119 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 168
TABLE 120 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 169
TABLE 121 EUROPE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 169
TABLE 122 EUROPE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 169
TABLE 123 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 170
TABLE 124 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 170
TABLE 125 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 170
TABLE 126 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 170
TABLE 127 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 171
TABLE 128 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 171
TABLE 129 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2022–2025 (USD MILLION) 171
TABLE 130 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2026–2031 (USD MILLION) 171
TABLE 131 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 172
TABLE 132 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 172
TABLE 133 GERMANY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 172
TABLE 134 GERMANY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 173
TABLE 135 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 173
TABLE 136 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 173
TABLE 137 UK: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 174
TABLE 138 UK: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 174
TABLE 139 UK: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 174
TABLE 140 UK: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 175
TABLE 141 FRANCE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 176
TABLE 142 FRANCE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 176
TABLE 143 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 176
TABLE 144 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 176
TABLE 145 NORWAY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 177
TABLE 146 NORWAY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 177
TABLE 147 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 177
TABLE 148 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 178
TABLE 149 ITALY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 178
TABLE 150 ITALY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 179
TABLE 151 ITALY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 179
TABLE 152 ITALY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 179
TABLE 153 SPAIN: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 180
TABLE 154 SPAIN: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 180
TABLE 155 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 180
TABLE 156 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 181
TABLE 157 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 181
TABLE 158 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 182
TABLE 159 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 182
TABLE 160 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 182
TABLE 161 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 183
TABLE 162 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 183
TABLE 163 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 183
TABLE 164 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 183
TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 185
TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 186
TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 186
TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 186
TABLE 169 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 187
TABLE 170 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 187
TABLE 171 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 187
TABLE 172 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 187
TABLE 173 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 188
TABLE 174 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 188
TABLE 175 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2022–2025 (USD MILLION) 188
TABLE 176 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2026–2031 (USD MILLION) 188
TABLE 177 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2022–2025 (USD MILLION) 189
TABLE 178 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2026–2031 (USD MILLION) 189
TABLE 179 CHINA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 190
TABLE 180 CHINA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 190
TABLE 181 CHINA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 190
TABLE 182 CHINA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 190
TABLE 183 INDIA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 191
TABLE 184 INDIA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 191
TABLE 185 INDIA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 192
TABLE 186 INDIA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 192
TABLE 187 JAPAN: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 193
TABLE 188 JAPAN: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 193
TABLE 189 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 193
TABLE 190 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 193
TABLE 191 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE,
2022–2025 (USD MILLION) 195
TABLE 192 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE,
2026–2031 (USD MILLION) 195
TABLE 193 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE,
2022–2025 (USD MILLION) 195
TABLE 194 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE,
2026–2031 (USD MILLION) 195
TABLE 195 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 196
TABLE 196 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 196
TABLE 197 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE,
2022–2025 (USD MILLION) 197
TABLE 198 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE,
2026–2031 (USD MILLION) 197
TABLE 199 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 198
TABLE 200 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 198
TABLE 201 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 198
TABLE 202 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 198
TABLE 203 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,
2022–2025 (USD MILLION) 199
TABLE 204 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,
2026–2031 (USD MILLION) 199
TABLE 205 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 199
TABLE 206 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 199
TABLE 207 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 200
TABLE 208 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 200
TABLE 209 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2022–2025 (USD MILLION) 200
TABLE 210 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2026–2031 (USD MILLION) 200
TABLE 211 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2022–2025 (USD MILLION) 201
TABLE 212 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2026–2031 (USD MILLION) 201
TABLE 213 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 202
TABLE 214 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 202
TABLE 215 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 202
TABLE 216 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 202
TABLE 217 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 203
TABLE 218 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 203
TABLE 219 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 203
TABLE 220 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 204
TABLE 221 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE,
2022–2025 (USD MILLION) 204
TABLE 222 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE,
2026–2031 (USD MILLION) 204
TABLE 223 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE,
2022–2025 (USD MILLION) 204
TABLE 224 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE,
2026–2031 (USD MILLION) 205
TABLE 225 ROW: OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 205
TABLE 226 ROW: OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 205
TABLE 227 ROW: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 206
TABLE 228 ROW: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 206
TABLE 229 ROW: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 206
TABLE 230 ROW: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 207
TABLE 231 ROW: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 207
TABLE 232 ROW: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 207
TABLE 233 ROW: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 207
TABLE 234 ROW: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 208
TABLE 235 ROW: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 208
TABLE 236 ROW: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 208
TABLE 237 ROW: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 208
TABLE 238 ROW: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 209
TABLE 239 AFRICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 209
TABLE 240 AFRICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 210
TABLE 241 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 210
TABLE 242 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 210
TABLE 243 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 211
TABLE 244 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 211
TABLE 245 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 211
TABLE 246 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 211
TABLE 247 OVERVIEW OF STRATEGIES ADOPTED BY KEY OMEGA-3 MARKET PLAYERS 213
TABLE 248 OMEGA-3 MARKET: MARKET SHARE ANALYSIS, 2025 216
TABLE 249 OMEGA-3 MARKET: REGIONAL FOOTPRINT, 2024 223
TABLE 250 OMEGA-3 MARKET: SOURCE FOOTPRINT, 2024 224
TABLE 251 OMEGA-3 MARKET: TYPE FOOTPRINT, 2024 225
TABLE 252 OMEGA-3 MARKET: APPLICATION FOOTPRINT, 2024 225
TABLE 253 OMEGA-3 MARKET: DETAILED LIST OF KEY STARTUPS/SMES 228
TABLE 254 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 229
TABLE 255 OMEGA-3 MARKET: PRODUCT LAUNCHES, JUNE 2022–JULY 2026 230
TABLE 256 OMEGA-3 MARKET: DEALS, DECEMBER 2022–JULY 2026 231
TABLE 257 OMEGA-3 MARKET: EXPANSIONS, FEBRUARY 2020–JULY 2026 233
TABLE 258 DSM-FIRMENICH: COMPANY OVERVIEW 234
TABLE 259 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 235
TABLE 260 DSM-FIRMENICH: PRODUCT LAUNCHES AND ENHANCEMENTS 236
TABLE 261 CARGILL, INCORPORATED: COMPANY OVERVIEW 238
TABLE 262 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 239
TABLE 263 CARGILL, INCORPORATED: DEALS 240
TABLE 264 BASF SE: COMPANY OVERVIEW 241
TABLE 265 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 242
TABLE 266 BASF SE: DEALS 243
TABLE 267 ADM: COMPANY OVERVIEW 244
TABLE 268 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 245
TABLE 269 KERRY GROUP PLC: COMPANY OVERVIEW 247
TABLE 270 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 248
TABLE 271 KERRY GROUP PLC: DEALS 249
TABLE 272 CORBION: COMPANY OVERVIEW 251
TABLE 273 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252
TABLE 274 CORBION: PRODUCT LAUNCHES AND ENHANCEMENTS 253
TABLE 275 CORBION: OTHER DEVELOPMENTS 253
TABLE 276 KD PHARMA GROUP SA: COMPANY OVERVIEW 254
TABLE 277 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 255
TABLE 278 KD PHARMA GROUP SA: DEALS 257
TABLE 279 KD PHARMA GROUP SA: EXPANSIONS 257
TABLE 280 AKER BIOMARINE: COMPANY OVERVIEW 259
TABLE 281 AKER BIOMARINE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 260
TABLE 282 AKER BIOMARINE: PRODUCT LAUNCHES AND ENHANCEMENTS 261
TABLE 283 AKER BIOMARINE: EXPANSIONS 262
TABLE 284 AKER BIOMARINE: DEALS 262
TABLE 285 AKER BIOMARINE: OTHER DEVELOPMENTS 265
TABLE 286 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW 266
TABLE 287 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 267
TABLE 288 EVONIK INDUSTRIES AG: COMPANY OVERVIEW 269
TABLE 289 EVONIK INDUSTRIES AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 270
TABLE 290 EVONIK INDUSTRIES AG: DEALS 271
TABLE 291 PELAGIA: COMPANY OVERVIEW 273
TABLE 292 PELAGIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 274
TABLE 293 PELAGIA: PRODUCT LAUNCHES AND ENHANCEMENTS 275
TABLE 294 PELAGIA AS: OTHER DEVELOPMENTS 275
TABLE 295 GC RIEBER: COMPANY OVERVIEW 277
TABLE 296 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 278
TABLE 297 GC RIEBER: PRODUCT LAUNCHES AND ENHANCEMENTS 279
TABLE 298 GC RIEBER: EXPANSIONS 279
TABLE 299 COOKE AQUACULTURE INC.: COMPANY OVERVIEW 281
TABLE 300 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281
TABLE 301 COOKE AQUACULTURE INC.: DEALS 283
TABLE 302 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW 284
TABLE 303 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 284
TABLE 304 ALGISYS BIOSCIENCES, INC.: OTHER DEVELOPMENTS 285
TABLE 305 POLARIS: COMPANY OVERVIEW 286
TABLE 306 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 286
TABLE 307 POLARIS: PRODUCT LAUNCHES AND ENHANCEMENTS 287
TABLE 308 POLARIS: OTHER DEVELOPMENTS 287
TABLE 309 BTSA: COMPANY OVERVIEW 288
TABLE 310 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 288
TABLE 311 NOVOSANA EUROPE B.V.: COMPANY OVERVIEW 290
TABLE 312 NOVOSANA EUROPE B.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 290
TABLE 313 GOLDEN OMEGA: COMPANY OVERVIEW 292
TABLE 314 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 292
TABLE 315 GOLDEN OMEGA: DEALS 293
TABLE 316 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW 294
TABLE 317 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 294
TABLE 318 RIMFROST AS: COMPANY OVERVIEW 296
TABLE 319 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 296
TABLE 320 RIMFROST AS: DEALS 297
TABLE 321 MARKETS ADJACENT TO OMEGA-3 MARKET 311
TABLE 322 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE,
2019–2023 (USD MILLION) 312
TABLE 323 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE,
2024–2029 (USD MILLION) 312
TABLE 324 MARINE COLLAGEN MARKET, BY FORM, 2022–2025 (USD MILLION) 313
TABLE 325 MARINE COLLAGEN MARKET, BY FORM, 2026–2031 (USD MILLION) 314

LIST OF FIGURES

FIGURE 1 OMEGA-3 MARKETS COVERED 30
FIGURE 2 STUDY YEARS CONSIDERED 32
FIGURE 3 MARKET SCENARIO 35
FIGURE 4 OMEGA-3 MARKET, 2022–2031 36
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET,
JULY 2021–MAY 2026 37
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF OMEGA-3 MARKET 38
FIGURE 7 OMEGA-3 MARKET: HIGH-GROWTH SEGMENTS, 2026–2031 39
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 40
FIGURE 9 INCREASING DEMAND FOR OMEGA-3 ACROSS FUNCTIONAL FOODS AND DIETARY SUPPLEMENTS TO SUPPORT MARKET GROWTH 41
FIGURE 10 TYPE SEGMENT DOCOSAHEXAENOIC ACID (DHA) AND NORTH AMERICA REGION TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026 42
FIGURE 11 OMEGA-3 DOCOSAHEXAENOIC ACID (DHA) TYPE SEGMENT TO LEAD MARKET
IN 2026 42
FIGURE 12 MARINE SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 43
FIGURE 13 BY FORM SEGMENT DRY FORM SEGMENT TO DOMINATE MARKET IN 2026 43
FIGURE 14 DIETARY SUPPLEMENTS APPLICATION SEGMENT TO DOMINATE MARKET IN 2026 43
FIGURE 15 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 44
FIGURE 16 OMEGA-3 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
FIGURE 17 RECOMMENDED EPA LEVELS IN DOG FOOD (MG) 50
FIGURE 18 MICROALGAE PROCESSING FOR OMEGA-3 55
FIGURE 19 OMEGA-3 MARKET: PORTER’S FIVE FORCES ANALYSIS 63
FIGURE 20 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP,
BY COUNTRY, 2023 66
FIGURE 21 GLOBAL POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION),
2014–2025 67
FIGURE 22 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS 68
FIGURE 23 OMEGA-3 MARKET ECOSYSTEM MAP 71
FIGURE 24 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE, 2025 (USD) 73
FIGURE 25 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON) 74
FIGURE 26 IMPORT OF HS CODE 1504, BY KEY COUNTRY, 2022–2025 (USD) 75
FIGURE 27 EXPORT OF HS CODE 1504, BY KEY COUNTRY, 2022–2025 (USD) 76
FIGURE 28 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES 78
FIGURE 29 INVESTMENT AND FUNDING SCENARIO 78
FIGURE 30 NUMBER OF PATENTS GRANTED BETWEEN 2016 AND 2026 88
FIGURE 31 FUTURE APPLICATIONS 89
FIGURE 32 OMEGA-3 MARKET DECISION-MAKING FACTORS 106
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES 107
FIGURE 34 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 108
FIGURE 35 ADOPTION BARRIERS AND INTERNAL CHALLENGES 109
FIGURE 36 OMEGA-3 MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 115
FIGURE 37 OMEGA-3 MARKET, BY SOURCE, 2026 VS. 2031 (USD MILLION) 122
FIGURE 38 OMEGA-3 MARKET, BY APPLICATION, 2026 VS. 2031 (USD MILLION) 137
FIGURE 39 OMEGA-3 MARKET, BY FORM, 2026 VS. 2031 (USD MILLION) 147
FIGURE 40 INDIA TO RECORD HIGHEST GROWTH RATE IN THE OMEGA-3 MARKET 156
FIGURE 41 NORTH AMERICA: REGIONAL SNAPSHOT 159
FIGURE 42 ASIA PACIFIC: REGIONAL SNAPSHOT 185
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS, 2023–2025 (USD BILLION) 215
FIGURE 44 OMEGA-3 MARKET SHARE ANALYSIS, 2025 216
FIGURE 45 COMPANY VALUATION FOR MAJOR PLAYERS IN OMEGA-3 MARKET 218
FIGURE 46 EV/EBITDA OF MAJOR PLAYERS 218
FIGURE 47 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON 219
FIGURE 48 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 222
FIGURE 49 OMEGA-3 MARKET: COMPANY FOOTPRINT, 2024 223
FIGURE 50 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 227
FIGURE 51 DSM-FIRMENICH: COMPANY SNAPSHOT 235
FIGURE 52 CARGILL, INCORPORATED: COMPANY SNAPSHOT 239
FIGURE 53 BASF SE: COMPANY SNAPSHOT 242
FIGURE 54 ADM: COMPANY SNAPSHOT 245
FIGURE 55 KERRY GROUP PLC: COMPANY SNAPSHOT 248
FIGURE 56 CORBION: COMPANY SNAPSHOT 252
FIGURE 57 KD PHARMA GROUP SA: COMPANY SNAPSHOT 255
FIGURE 58 AKER BIOMARINE: COMPANY SNAPSHOT 260
FIGURE 59 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT 267
FIGURE 60 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT 270
FIGURE 61 PELAGIA: COMPANY SNAPSHOT 274
FIGURE 62 GC RIEBER: COMPANY SNAPSHOT 278
FIGURE 63 OMEGA-3 MARKET: RESEARCH DESIGN 301
FIGURE 64 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION,
AND REGION 303
FIGURE 65 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 305
FIGURE 66 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 306
FIGURE 67 OMEGA-3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 307
FIGURE 68 DATA TRIANGULATION 308

---

---